Alexander J Lazar

Alexander J Lazar

UNVERIFIED PROFILE

Are you Alexander J Lazar?   Register this Author

Register author
Alexander J Lazar

Alexander J Lazar

Publications by authors named "Alexander J Lazar"

Are you Alexander J Lazar?   Register this Author

100Publications

4366Reads

35Profile Views

Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the , , and Genes: A Study of the College of American Pathologists Molecular Oncology Committee.

Arch Pathol Lab Med 2019 Oct 10;143(10):1203-1211. Epub 2019 Apr 10.

From the Office of the Director, The Joint Pathology Center, Silver Spring, Maryland (Dr Moncur); the Department of Pathology, St Joseph Mercy Hospital, Ypsilanti, Michigan (Dr Bartley); the Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha (Dr Bridge); the Department of Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada (Dr Kamel-Reid); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Lazar); the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Drs Lindeman and Kim); Biostatistics (Mr Long) and Proficiency Testing (Ms Vasalos), College of American Pathologists, Northfield, Illinois; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill (Dr Merker); the Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York (Dr Rai); the Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (Dr Rimm); and the Department of Pathology and Laboratory Medicine, Strong Memorial Hospital, University of Rochester Medical Center and Pathology and Laboratory Medicine, Molecular Diagnostic Laboratory, Rochester, New York (Dr Rothberg). Dr Moncur is employed by the US Army. The identification of specific products or scientific instrumentation is considered an integral part of the scientific endeavor and does not constitute endorsement or implied endorsement on the part of the authors, the Department of Defense, or any component agency. The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Army/Navy/Air Force, Department of Defense, or US government. The other authors have no relevant financial interest in the products or companies described in this article.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2018-0396-CPDOI Listing
October 2019

Are ALK Rearrangements Found in Smooth Muscle Tumors of the Gastrointestinal Tract?

Histopathology 2019 Oct 9. Epub 2019 Oct 9.

The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14013DOI Listing
October 2019

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.

Front Immunol 2018 19;9:2102. Epub 2018 Sep 19.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2018.02102
Publisher Site
http://dx.doi.org/10.3389/fimmu.2018.02102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156434PMC
September 2019

Toward an effective use of β-catenin immunohistochemistry in the evaluation of challenging melanocytic lesions.

Virchows Arch 2019 05 13;474(5):535-537. Epub 2019 Mar 13.

Departments of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 85, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-019-02552-6DOI Listing
May 2019

Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays.

Arch Pathol Lab Med 2019 Apr 30;143(4):463-471. Epub 2018 Oct 30.

From the Departments of Pathology and Laboratory Medicine & Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill (Dr Merker); the Departments of Pathology (Drs Devereaux and Montgomery, and Mr Smail) and Genetics (Dr Montgomery), Stanford University School of Medicine, and the Biomedical Informatics Program (Mr Smail), Stanford University, Stanford, California; the Department of Pathology, Massachusetts General Hospital (Dr Iafrate), and the Department of Pathology, Brigham and Women's Hospital (Drs Kim and Lindeman), Harvard University, Boston; the Departments of Pathology and Clinical Laboratory Genetics, The University Health Network and the University of Toronto, Toronto, Ontario, Canada (Dr Kamel-Reid); the Department of Pathology, Walter Reed National Military Medical Center, Bethesda, Maryland (Dr Moncur); PierianDx, St Louis, Missouri (Dr Nagarajan); the Department of Global Medical Affairs, Roche, Tucson, Arizona (Dr Portier); the Departments of Hematopathology (Dr Routbort) and Pathology, Genomic Medicine, and Translational Molecular Pathology (Dr Lazar), he University of Texas MD Anderson Cancer Center, Houston (Dr Routbort); the Department of Pathology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia (Dr Surrey); and Proficiency Testing, College of American Pathologists, Northfield, Illinois (Ms Vasalos).

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/10.5858/arpa.2018-033
Publisher Site
http://dx.doi.org/10.5858/arpa.2018-0336-CPDOI Listing
April 2019

Long-Term Outcomes for Patients With Desmoid Fibromatosis Treated With Radiation Therapy: A 10-Year Update and Re-evaluation of the Role of Radiation Therapy for Younger Patients.

Int J Radiat Oncol Biol Phys 2019 04 12;103(5):1167-1174. Epub 2018 Dec 12.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.12.012DOI Listing
April 2019

Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma.

J Invest Dermatol 2019 Mar 25;139(3):728-731. Epub 2018 Oct 25.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2018.10.009DOI Listing
March 2019

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.

Cancer Cell 2019 02;35(2):204-220.e9

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2019.01.006DOI Listing
February 2019

PAX7 expression in sarcomas bearing the EWSR1-NFATC2 translocation.

Mod Pathol 2019 01 9;32(1):154-156. Epub 2018 Jul 9.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0095-6DOI Listing
January 2019

TERT promoter mutations in solitary fibrous tumour.

Histopathology 2018 Nov 19;73(5):843-851. Epub 2018 Sep 19.

Pathology and Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13703DOI Listing
November 2018

Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.

Gynecol Oncol 2018 11 5;151(2):243-249. Epub 2018 Sep 5.

Graduate School of Biomedical Sciences, University of Texas at Houston Health Science Center, Houston, TX, United States; University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.08.043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214727PMC
November 2018

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Arch Pathol Lab Med 2018 10 5;142(10):1242-1253. Epub 2018 Mar 5.

Jason D. Merker and Maximilian Diehn, Stanford University School of Medicine; Stanford, CA; Geoffrey R. Oxnard, Dana Farber Cancer Institute and Harvard Medical School; Neal Lindeman, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Carolyn Compton, Arizona State University, Tempe, AZ; Patricia Hurley, Richard L. Schilsky, Thomas K. Oliver, and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Alexander J. Lazar and Apostolia M. Tsimberidou, The University of Texas MD Anderson Cancer Center, Houston, TX; hristina M. Lockwood, University of Washington, Seattle, WA; Alex J. Rai, Columbia University Medical Center, New York, NY; Patricia Vasalos and Brooke L. Billman, College of American Pathologists, Northfield, IL; Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Nicholas C. Turner, Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/10.5858/arpa.2018-090
Publisher Site
http://dx.doi.org/10.5858/arpa.2018-0901-SADOI Listing
October 2018

Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.

Mod Pathol 2018 10 24;31(10):1553-1559. Epub 2018 May 24.

Department of Pathology, Unit 85, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0080-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168348PMC
October 2018

Role of Elevated Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.

Clin Cancer Res 2018 09 18;24(17):4119-4125. Epub 2018 May 18.

Center for Melanoma Research and Treatment, California Pacific Medical Center (CPMC) Research Institute, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125189PMC
September 2018

Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report.

J Glob Oncol 2018 09 6;4:1-6. Epub 2017 Jul 6.

Anthony P. Conley, Van Anh Trinh, Chrystia M. Zobniw, Kristi Posey, Wei-Lien Wang, Alexander J. Lazar, Neeta Somaiah, Jason Roszik, and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX; Jaime D. Martinez, Universidad Nacional Autonoma de Mexico; and Oscar G. Arrieta, Instituto Nacional de Cancerologia, Mexico City, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2017.009993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180844PMC
September 2018

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

J Clin Oncol 2018 06 5;36(16):1631-1641. Epub 2018 Mar 5.

Jason D. Merker and Maximilian Diehn, Stanford University School of Medicine; Stanford, CA; Geoffrey R. Oxnard, Dana Farber Cancer Institute and Harvard Medical School; Neal Lindeman, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Carolyn Compton, Arizona State University, Tempe, AZ; Patricia Hurley, Richard L. Schilsky, Thomas K. Oliver, and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Alexander J. Lazar and Apostolia M. Tsimberidou, The University of Texas MD Anderson Cancer Center, Houston, TX; Christina M. Lockwood, University of Washington, Seattle, WA; Alex J. Rai, Columbia University Medical Center, New York, NY; Patricia Vasalos and Brooke L. Billman, College of American Pathologists, Northfield, IL; Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Nicholas C. Turner, Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8671DOI Listing
June 2018

The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center.

J Surg Oncol 2018 Jun 3;117(8):1799-1805. Epub 2018 May 3.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25082DOI Listing
June 2018

The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma.

Cancer Cell 2018 06 31;33(6):1128-1141.e7. Epub 2018 May 31.

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA; Epigenomics Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791822PMC
June 2018

Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in -Mutant Melanoma.

JCO Precis Oncol 2018 5;2018. Epub 2018 Jun 5.

Junna Oba, Sun-Hee Kim, Wei-Lien Wang, Mariana P. Macedo, Fernando Carapeto, Meredith A McKean, John Van Arnam, Agda K. Eterovic, Shiraj Sen, Charuta R. Kale, Xiaoxing Yu, Cara L. Haymaker, Mark Routbort, Lauren E. Haydu, Chantale Bernatchez, Alexander J. Lazar, Elizabeth A. Grimm, David S. Hong, and Scott E. Woodman, The University of Texas MD Anderson Cancer Center, Houston, TX; and Mariana P. Macedo, AC Camargo Cancer Center, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080631PMC
http://dx.doi.org/10.1200/PO.18.00055DOI Listing
June 2018

PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.

J Pathol 2018 04 22;244(5):512-524. Epub 2018 Feb 22.

Departments of Pathology, Genomic Medicine, and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240356PMC
April 2018

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

Cell Rep 2018 04;23(1):227-238.e3

Department of Medicine, Washington University in St. Louis, St. Louis, MO 63110, USA; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO 63108, USA; Department of Genetics, Washington University in St. Louis, St. Louis, MO 63110, USA; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO 63110, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.03.050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916809PMC
April 2018

Genomic and Functional Approaches to Understanding Cancer Aneuploidy.

Cancer Cell 2018 04 2;33(4):676-689.e3. Epub 2018 Apr 2.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Cancer Program, Broad Institute, 415 Main Street, Cambridge, MA 02142, USA; Department of Pathology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.03.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028190PMC
April 2018

Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.

Curr Oncol Rep 2018 03 26;20(5):37. Epub 2018 Mar 26.

Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-018-0668-zDOI Listing
March 2018

Primary chondro-osseous melanoma (chondrosarcomatous and osteosarcomatous melanoma).

J Cutan Pathol 2018 Feb 6;45(2):146-150. Epub 2017 Dec 6.

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.13067DOI Listing
February 2018

Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas.

Histopathology 2018 Jan 19;72(2):239-247. Epub 2017 Oct 19.

Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13337DOI Listing
January 2018

Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model.

Mod Pathol 2017 10 21;30(10):1433-1442. Epub 2017 Jul 21.

Department of Pathology and Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.54DOI Listing
October 2017

EWSR1 fusion proteins mediate PAX7 expression in Ewing sarcoma.

Mod Pathol 2017 09 23;30(9):1312-1320. Epub 2017 Jun 23.

Departments of Pathology &Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.49DOI Listing
September 2017

Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy.

Ann Surg Oncol 2017 Aug 10;24(8):2145-2154. Epub 2017 Apr 10.

Department of Orthopaedic Oncology - Unit 1448, MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-5855-xDOI Listing
August 2017

Molecular profiling of sarcomas: new vistas for precision medicine.

Virchows Arch 2017 Aug 29;471(2):243-255. Epub 2017 Jun 29.

Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Boulevard-Unit 85, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-017-2174-3DOI Listing
August 2017

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.

Clin Sarcoma Res 2017 15;7:11. Epub 2017 Jun 15.

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13569-017-0077-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471883PMC
June 2017

Synovial Sarcoma of the Head and Neck: A Single Institution Review.

Sarcoma 2017 5;2017:2016752. Epub 2017 Jun 5.

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/2016752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474548PMC
June 2017

The role of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) in peripheral nerve sheath tumours.

Histopathology 2017 May 9;70(6):946-953. Epub 2017 Feb 9.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13154DOI Listing
May 2017

Trends in hepatocyte growth factor, insulin-like growth factor 1, thyroid-stimulating hormone, and leptin expression levels in uveal melanoma patient serum and tumor tissues: correlation to disease progression.

Melanoma Res 2017 04;27(2):126-133

Departments of aMelanoma Medical Oncology bOrbital Oncology and Ophthalmic Plastic Surgery cPlastic Surgery and Biostatistics dPathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA eDepartment of Pathology, AC Camargo Cancer Center, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000329DOI Listing
April 2017

Undifferentiated "round" cell ("Ewing-like") sarcoma: not always so-round nor Ewing-like.

Virchows Arch 2017 04 13;470(4):371-372. Epub 2017 Feb 13.

Departments of Pathology & Translational Molecular Pathology; Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-017-2080-8DOI Listing
April 2017

IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.

J Natl Cancer Inst 2016 12 30;108(12). Epub 2016 Aug 30.

Departments of Sarcoma Medical Oncology (SELC, BAM, VR, RSB, RR, JAL), Hematopathology (DV, HMA), Bioinformatics and Computational Biology (YW, JW), Investigational Cancer Therapeutics (AN, VS), Pediatrics-Patient Care (NCD), Experimental Therapeutics (IF, SS, WP), and Pathology (AJL), The University of Texas MD Anderson Cancer Center, Houston, TX; Departments of Radiology (EMR) and Molecular & Human Genetics (RLM), Baylor College of Medicine, Houston, TX; Department of Pediatric-Oncology, Texas Children's Hospital. Houston, TX (ASB); Departments of Chemical and Biomolecular Engineering and Bioengineering, Rice University, Houston, TX (AGM)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241894PMC
December 2016

Sarcoma Brain Metastases: 28 Years of Experience at a Single Institution.

Ann Surg Oncol 2016 12 19;23(Suppl 5):962-967. Epub 2016 Sep 19.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5559-7DOI Listing
December 2016

Cutaneous nodular fasciitis with genetic analysis: a case series.

J Cutan Pathol 2016 Dec;43(12):1143-1149

Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12828DOI Listing
December 2016

Myxofibrosarcoma.

Surg Oncol Clin N Am 2016 10 30;25(4):775-88. Epub 2016 Jul 30.

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1484, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2016.05.008DOI Listing
October 2016

Non-Radiographic Risk Factors Differentiating Atypical Lipomatous Tumors from Lipomas.

Front Oncol 2016 22;6:197. Epub 2016 Sep 22.

Department of Orthopaedic Oncology, MD Anderson Cancer Center, Houston, TX, USA; Sarcoma Research Center, Houston, TX, USA; MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2016.00197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031604PMC
September 2016